ClinPhone Now Leading Growth Of Technology Companies In The Pharmaceutical Sector
- May 8, 2003
Award-winning Clinical Technology Organisation the ClinPhone Group has announced record turnover and profit for the financial year to February 2003.
Turnover is 34% ahead of the same period in 2002 and profit is up by 20%. The past year has also seen the company increase both the number of major projects and large clients significantly.
The number of major pharmaceutical organisations that see the benefit of the broad range of services that ClinPhone has to offer increased again last year. ClinPhone now does substantial work for 16 of the Top 20 pharmaceutical organisations in the world.
"These are excellent statistics in what is acknowledged as a tough economic climate for the industry," commented Group Financial Director, Steven Kent. "What we believe they demonstrate is a growing recognition by the worldwide pharmaceutical industry that ClinPhone is at the top of the tree in terms of value-added technology which reduces the costs of clinical trials and brings products to market quickly.
"We have seen an increase in the complexity of the work we carry out for our customers and in the geographical spread of that work. We are also now known and utilised on a large scale by most of the world's top pharmaceutical companies.